Lactobacillus crispatus VPro 31 and Improved Tolerability of Lactobacillus crispatus CTV-05

• Phase I Trial of a Lactobacillus crispatus Vaginal Suppository for Prevention of Recurrent Urinary Tract Infection in Women

  • 2008-03-11
  • RCT · n = 30
  • Infectious Diseases in Obstetrics and Gynecology 2007
  • • C. Czaja
    • A. Stapleton
    • Yuliya Yarova-Yarovaya
    • W. Stamm

  • PubMed: 18288237
  • DOI: 10.1155/2007/35387

  12 Insights on

  • Improved Tolerability of Lactobacillus crispatus CTV-05

  • High evidence
  • Highly Cited

  L. crispatus CTV-05 can be given as a vaginal suppository with minimal side effects to healthy women with a history of recurrent UTI.

  Effect

  Neutral

  Effect size

  Moderate